Michael J. Fox Foundation
Global Parkinson's Genetics Program Signs up Psomagen for Large-Scale Whole-Genome Sequencing Study
Psomagen will sequence the genomes of approximately 80,000 individuals as part of a global effort to understand the genetic architecture of Parkinson's disease.
Centogene, Michael J. Fox Foundation to Study Genetic Risk Factors of Parkinson's Disease
The research project will leverage multiomic data in Centogene’s databank, which includes over 15,000 PD datasets from the company’s previous study.
Octave Bioscience Wins $10M Grant From Michael J. Fox Foundation
The firm will use the funds to develop a protein panel that can help assess disease activity and progression in individuals with Parkinson's.
In work supported by the Michael J. Fox Foundation, the researchers identified protein markers for the condition in extracellular vesicles collected from urine.
Erisyon Wins $189K Michael J. Fox Foundation Grant for Protein Biomarker Discovery
Erisyon will use its single-molecule protein sequencing technology to detect and validate biomarkers for early detection of Parkinson's disease.